Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy

Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. In basic studies, the regulation of autophagy has offered promising results for HCC treatment. This study aimed to address the question of whether amiodarone can improve survival rates in HCC patients associated with autophagy. Usi...

Full description

Bibliographic Details
Main Authors: Sheng-Teng Huang, Wei-Fan Hsu, Hung-Sen Huang, Jia-Hau Yen, Mei-Chen Lin, Cheng-Yuan Peng, Hung-Rong Yen
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:International Journal of Molecular Sciences
Subjects:
amiodarone
autophagy
hepatocellular carcinoma
National Health Insurance Research Database
Online Access:https://www.mdpi.com/1422-0067/20/16/3978

Internet

https://www.mdpi.com/1422-0067/20/16/3978

Similar Items